A study led by Dr. Peter Canoll's lab, in collaboration with researchers at Columbia University Irving Medical Center, ...

The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among ...

This study presents a new prognostic model using mitophagy-related genes (MRGs) in glioma, a type of brain tumor, developed through bioinformatics. The model seeks to improve the understanding of ...

Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for ...

That was on Nov. 25. This time, Chen, as part of a clinical trial at Rhode Island Hospital used a radiation treatment, on the ...

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

When deciding if reoperation is an option in recurrent glioblastoma, factors like tumor location, therapy history and patient health should be considered.

CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...

Glioblastoma (GBM), an aggressive form of cancer that grows in the brain or spinal cord, occurs at an incidence rate of about 3/100,000 persons in the Unit | Cancer ...

“Besides, the novel experimental mouse model we developed provides a powerful way to study the effects of stimulus-evoked activity on glioma growth. Many researchers in the field of cancer ...

Scientists have developed an innovative method for growing brain tumors of individual patients in the laboratory that mimic the original structure and the molecular property of the parental tumor as ...